Table 1.
Patient characteristics in the survivor and non-survivor groups
| Characteristic | Survivors (n=33) | Non-survivors (n=41) | p-value |
|---|---|---|---|
| Age (yr) | 53.24±2.633 | 59.32±2.490 | 0.100 |
| Sex (male) | 16 (48.5) | 17 (41.5) | 0.546 |
| Body mass index (kg/m2) | 25.3±0.645 | 24.44±0.654 | 0.356 |
| Comorbidities | |||
| Hypertension | 14 (42.4) | 20 (48.8) | 0.585 |
| Diabetes mellitus | 6 (18.2) | 9 (22.0) | 0.688 |
| Chronic kidney disease | 3 (9.1) | 4 (9.8) | 1.000 |
| Malignancy | 5 (15.2) | 10 (24.4) | 0.326 |
| Immunosuppression | 8 (24.2) | 13 (31.7) | 0.479 |
| Intensive care unit score | |||
| APACHE II | 13.27±5.642 | 14.83±5.603 | 0.240 |
| SOFA | 6.48±3.938 | 6.63±2.300 | 0.848 |
| RESP | -0.55±3.133 | -1.51±3.107 | 0.189 |
| ECMO mode (venovenous mode) | 31 (93.9) | 34 (82.9) | 0.283 |
| Duration of MV support prior to ECMO initiation (day) | 4.42±7.018 | 2.68±3.745 | 0.176 |
| Cause of ARDS | |||
| Sepsis | 2 (6.1) | 6 (14.6) | 0.286 |
| Pneumonia | 27 (81.8) | 32 (78.0) | 0.688 |
| Aspiration | 1 (3.0) | 0 | 0.446 |
| Massive transfusion | 3 (9.1) | 3 (7.3) | 1.000 |
| Trauma | 0 | 1 (2.4) | 1.000 |
| Already on CRRT before ECMO initiation | 2 (6.1) | 7 (17.1) | 0.283 |
| New start of CRRT | 12 (36.4) | 17 (42.5) | 0.594 |
Values are presented as mean±standard deviation or number (%).
APACHE, Acute Physiology And Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment; RESP, Respiratory Extracorporeal Membrane Oxygenation Survival Prediction; ECMO, extracorporeal membrane oxygenation; MV, mechanical ventilation; ARDS, acute respiratory distress syndrome; CRRT, continuous renal replacement therapy.